Pfizer to buy NextWave Pharma for $700 mln

By Admin
Largest research-based pharmaceutical company Pfizer will buy NextWave Pharmaceuticals Inc. NextWave is a company that makes a liquid attention deficit...

Largest research-based pharmaceutical company Pfizer will buy NextWave Pharmaceuticals Inc. NextWave is a company that makes a liquid attention deficit hyperactivity disorder drug in a deal worth as much as $700 million.

In September, the Food and Drug Administration approved NextWave’s drug Quillivant XR in September. The once-per-day drug is expected to be in pharmacies in January.

To establish a merger agreement, Pfizer made a $20 million option payment to California-based NextWave in the second quarter.

When the deal closes, the company will pay $255 million and has also agreed to pay NextWave another $425 million based on sales milestones.

According to Pfizer, about 9.5% of children have received a diagnosis of ADHD at some point, and around 4% of adults have the condition.

Using the same drug, NextWave is also developing extended release chewable tablets. It has an advanced-stage study of the tablets in process and aims to submit the product for approval next year.

Subject to regulatory approval, Pfizer expects to close the deal during the fourth quarter.

Pfizer Inc is an American multinational company based in New York City.  The company develops and produces medicines and vaccines for wide range of conditions including in areas of immunology and inflammation, oncology, cardiovascular and metabolic diseases, neuroscience and pain.

Share
Share

Featured Articles

Why clinical AI is the future of healthcare

Harish Battu from General Catalyst explores the use of AI in healthcare, the challenges of its adoption & what it means for healthcare technology

AI can help healthcare workers deliver compassionate care

Dr. Lance Owens, Chief Medical Information Officer at the University of Michigan Health-West, explains how AI technology can support healthcare workers

Digital healthcare platform Balanced supports healthy ageing

10,000 people turn 65 in the USA each day. Digital healthcare platform Balanced wants to help them better manage healthy ageing, says CEO Katie Reed

TrueBinding’s antibody drugs fight Alzheimer’s Disease

Medical Devices & Pharma

Cardinal Health’s clinically integrated pharma supply chain

Medical Devices & Pharma

Healthcare Digital news roundup: digital healthcare & AI

Digital Healthcare